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ABSTRACT 
The study was devised to evaluate the effect of total protein, albumin content, 
enzymatic property and lipid profile in rats’ plasma after chronic administration 
of Balajirakadi Kvatha Curna (BLJ), a classical Ayurvedic preparation that is 
widely used in cough. The drug was administered per oral route at a dose of 40 
ml/kg of the body weight for 45 consecutive days. Eight-week old albino rats 
(Rattus novergicus : Sprague - Dawley strain,) of both sexes, bred and maintained 
at the Animal House of the Department of Pharmacy, Jahangirnagar University 
were used for the experiment. All experiments on rats were carried out in 
absolute compliance with the ethical guide for care and use of laboratory animals. 
After the administration of BLJ preparation for a period of 45 days, the following 
biochemical parameters (protein, albumin, triglyceride, cholesterol, LDL, VLDL, 
HDL, sGPT sGOT and ALP) in the plasma of both the male and female rats were 
determined. An increased level of Total protein, the Albumin content and 
triglyceride in the plasma found in the both male and female rats, none of these 
changes were significantly different from their corresponding control values but 
noticeable. On the contrary in both female and male rats the decreased level in 
the total Cholesterol, VLDL, LDL and HDL was noticed and among which Total 
Cholesterol and VLDL are significant. Surprisingly the LDL content was almost 
similar to the corresponding control value and decrease in HDL was not 
significant. A statistically very highly significant increase in the sGPT sGOT and 
ALP activities in the plasma of male rats was found while in the female rats it has 
been showed a statistically very highly significant decrease in sGPT and sGOT but 
ALP activities in the plasma was statistically insignificant.  
KEY WORDS: Ayurvedic, Lipid profile, Triglycerides, chronic, Albino. 
INTRODUCTION 
Ayurvedic medicine (also called 
Ayurveda) is one of the world's oldest 
medical systems. It originated in India and 
has evolved there over thousands of years. 
In Bangladesh, Ayurvedic medicine is 
considered complementary and alternative 
medicine (CAM) more specifically, a CAM 
whole medical system. Many therapies used 
in Ayurvedic medicine are also used on their 
own as CAM—for example, herbs, massage, 
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and specialized diets. Ayurvedic medicines 
are multi-components mixture containing 
plants, animal derived products, minerals 
and metals[1-4]. By using Ayurvedic medicine, 
expensive and extensive procedures of clinical 
investigations can be avoided in many cases 
and people in many areas have the choice to 
get treatment at a cheaper price depending on 
their choice. Considering the widespread use 
of Ayurveda as the popular form of 
treatment in Bangladesh, one cannot 
emphasize enough the need for establishing 
the safety profiles of Ayurvedic drugs[5-7]. 
Large numbers of modern medicinal agents 
have been sourcing from the nature in the 
past[8]. Natural plants and their constituents 
are giving the primary ideas about the 
treatment of new diseases. Hence, natural 
medicine like Ayurvedic drugs still remain a 
popular practice in the subcontinent 
including India, Sri Lanka and other 
countries like Bangladesh[9-10]. Ayurvedic 
medicines have a wide access to the large 
number of population in these countries. 
The acceptance of these medicines increased 
due to integrative approach for the 
prevention and treatment of disease through 
natural remedies. Traditional people are 
getting the benefits of this practice from 
ancient times. But, the uses and the safety 
profile of all of the Ayurvedic medicines are 
not ensured scientifically [11-12].  
Balajirakadi Kvatha Curna is included 
in the Bangladesh National Formulary of 
Ayurvedic Medicine 1992 which was 
approved by the Government of Bangladesh 
via Ministry of Health and Family Welfare. 
This drug is widely used in cough by the 
relatively economic people in our 
community to avoid extra expense[13-15]. The 
objective is to have a better understanding 
of the possible toxicological profile of the 
drug under study and, to some degree, to 
decide how justifiable the use of this drug is 
under the stated circumstances. This study 
was performed in an effort to evaluate the 
safety of this drug according to modern 
toxicological parameters. The present study 
is the continuation of the effort in which the 
toxicological effect of BLJ on total protein, 
albumin content, lipid profile and enzymatic 
property of rats’ plasma after chronic 
administration. 
MATERIALS AND METHODS 
Chemicals and Reagents 
For the evaluation of the toxicological 
effect of BLJ on total protein, albumin 
content, lipid profile and enzymatic property 
of rats’ plasma after chronic administration, 
various chemicals and reagents were used. 
All chemicals and reagents were of analytical 
grade and these were collected from Sri 
Kundeswari Aushadhalaya Ltd, Chittagong. 
These chemicals and reagents were 
prepared with glass-distilled water.  
Preparation of drug 
For the toxicological study 
Balajirakadi Kvatha Curna (BLJ) was collected 
from Sri Kundeswari Aushadhalaya Ltd, 
Chittagong. The extract (known as kwath) 
was prepared from dried powder according 
to the procedure mentioned in Bangladesh 
National Ayurvedic Formulary (BNAF), 1992. 
The Kwath was prepared by adding 160ml of 
distilled water with 5gm of the powder and it 
was thoroughly mixed to make a uniform 
suspension, it was then boiled till the volume 
was reduced to 40ml and was finally filtered. 
This filtrate was collection I. Then residue 
was again boiled with 160ml of water till the 
volume was reduced to 40ml and was then 
filtered. This filtrate was collection II. The 
two filtrates (collection I and II) were mixed 
and reduced to 20ml and this mixture was 
known as Kwath and was used for the 
toxicological study. For the toxicological 
experiment, the KWATH was administered at 
a volume such that it would permit optimal 
dosage accuracy.  
Formulary of Balajirakadi Kvatha Curna 
(BLJ) 
For the preparatoon of Balajirakadi 
Kvatha Curna (BLJ), ingredients are taken as 
per table no -1 with their classified family 
and botanical name. The parts and amont 
used are listed in the table no-1. 
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Table 1: Formulary of Balajirakadi Kvatha Curna (BLJ) 
Ayurvedic/ 
Traditional Name 
Parts Used Botanical Name Family Amount 
used 
Bala Root Sida Cordifolia Malvaceae 1 Part 
Jiraka Fruit Cuminum cyminum Apiaceae 1 Part 
Bilva Root Aegle mermelos Rutaceae 1 Part 
Abda Rhyzome Cyperus rotundus Cyperaceae 1 Part 
Vrsa Root Adhatoda vasaka Acanthaceae 1 Part 
Visva (sunthi) Rhyzome Zingiber officinalis Zingiberaceae 1 Part 
Suradruma 
(devadaru) 
Heart Wood Cedrus deodara Pinaceae 1 Part 
Guha (salaparni) Pulp Pseudarthria viscida Fabaceae 1 Part 
Iksu Root Saccharum officianarum Poaceae 1 Part 
Laja Stem Lathyrus japonicas Fabaceae 1 Part 
Route of Administration 
For the toxicological studies, the drug 
was administered per oral route at a dose of 
40 ml/kg of the body weight. [Per oral (p.o.) 
route]. Ketamine were administered intra-
peritoneal (500 mg/kg i.p.). 
Management of Experimental Animal 
Eight-week old albino rats (Rattus 
novergicus : Sprague - Dawley strain,) of 
both sexes, bred and maintained at the 
Animal House of the Department of 
Pharmacy, Jahangirnagar University were 
used in the toxicological experiment. These 
animals were apparently healthy and 
weighed 50 - 70 g.  
Animal Care 
The animals were housed in a well 
ventilated hygienic experimental animal 
house under constant environmental and 
adequate nutritional conditions throughout 
the period of the experiment. All of the rats 
were kept in plastic cages having dimensions 
of 30 x 20 x 13 cm and soft wood shavings 
were employed as bedding in the cages. 
Feeding of animals was done ad libitum, 
along with drinking water and maintained at 
natural day night cycle. They were fed with 
“mouse chow” (prepared according to the 
formula developed at BCSIR, Dhaka). All 
experiments on rats were carried out in 
absolute compliance with the ethical guide 
for care and use of laboratory animals. 
Before starting an experiment the animals 
were carefully marked on different parts of 
their body, which was later used as 
identification mark for a particular animal, 
so that the response of a particular rat prior 
to and after the administration could be 
noted separately.  
Controls 
A group of equal number of rat as the 
drug treated group was simultaneously 
employed in the experiment. They were 
administered with distilled water as placebo 
as per the same volume as the drug treated 
group for the same number of days and this 
group served as the control. Prior to the 
experiment, they were randomly divided 
into 4 groups of 10 animals according to sex. 
Thus ten rats were taken for each group for 
both control and the experimental group. 
Toxicological experiment 
After acclimatization, administration 
of the Ayurvedic medicinal preparation was 
done by intra-gastric syringe. 
Administration of the extract was between 
the hours of 10 am and noon. At the due of 
the 45-days treatment period, the animals 
were fasted for 18 hours and also twenty-
four hours after the last administration, the 
animals were anaesthetized using i.p. 
Ketamine (500 mg/kg i.p.). Blood samples 
were collected from post vena cava and 
transferred into heparinised tubes 
immediately. Blood was then centrifuged at 
4,000 g for 10 min using bench top 
centrifuge (MSE Minor, England) to remove 
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red blood cells and recover plasma. Plasma 
samples were separated and were collected 
using dry Pasteur pipette and stored in the 
refrigerator for analyses. All analyses were 
completed within 24 h of sample collection. 
All other reagents and chemicals that were 
used in this work were of analytical grade 
and were prepared in all glass-distilled 
water. 
Statistical Analysis 
The group data are expressed as 
Mean ± SEM (Standard Error of the Mean). 
Unpaired "t" tests were done for statistical 
significance tests. SPSS (Statistical Package 
for Social Science) for WINDOWS (Ver. 11) 
was applied for the analysis of data. 
Differences between groups were 
considered significant at p < 0.05, 0.01 and 
0.001. Note: denoted accordingly as *p<0.05, 
**p<0.01, ***p<0.001[16] (*,**, and *** mean 
noticeable, high and very high significant 
respectively) 
Test procedure for Total Protein 
Only one blank is required for a series 
of tests. For blank 1000l Total Protein 
reagents, for standard 1000l Total Protein 
reagents and 20l Protein standard and for 
test sample 1000l Total Protein reagents 
with 20l Serum/Plasma were mixed well 
and then incubated at incubate at 20C to 
25C for 10 minutes. Finally, read the result 
with 
Analyzer/Colorimeter/Spectrophotometer 
against Reagent Blank 
Test procedure for Albumin 
Only one blank is required for a series 
of tests. For blank 1000l Albumin reagents, 
for standard 1000l Albumin reagents and 
10l Albumin standard and for test sample 
1000l Albumin reagents with 10l 
Serum/Plasma were mixed well and then 
incubated at incubate at 20C to 25C for 5 
minutes. Finally, read the result with 
Analyzer/Colorimeter/Spectrophotometer 
against Reagent Blank. 
Test procedure for Triglycerides 
Only one blank is required for a series 
of tests. For blank 1000l TG (Triglycerides) 
reagents, for standard 1000l TG reagents 
and 10l TG standard and for test sample 
1000l TG reagents with 10l 
Serum/Plasma were mixed well and then 
incubated at incubate at 37C for 5 minutes 
or room temperature for 10-15 minutes. 
Finally, read the result with Analyzer/ 
Colorimeter/ Spectrophotometer against 
Reagent Blank. 
Test Procedure Total Cholesterol  
Only one blank is required for a series 
of tests. For blank 1000l Cholesterol 
reagents, for standard 1000l Cholesterol 
reagents and 10l Cholesterol standard and 
for test sample 1000l Cholesterol reagents 
with 10l Serum/Plasma were mixed well 
and then incubated at incubate at 37C for 5 
minutes or room temperature for 10-15 
minutes. Finally, read the result with 
Analyzer/ Colorimeter/ Spectrophotometer 
against Reagent Blank. 
Test Procedure Total HDL-Cholesterol  
This procedure includes two steps- 
Precipitation step involves Precipitate 
reagent (PREC) and total cholesterol 
determination. For macro, 1000l 
Precipitate Reagents and 500l of serum are 
mixed and Incubated for 10 minutes at room 
temp. In semi micro 500l Diluted PREC and 
200l of serum are mixed and Incubated for 
10 minutes at room temp. Finally they were 
centrifuged for 10 minutes at 4000 g. After 
Centrifugation, Supernatant was collected 
For total cholesterol determination 
only one blank is required for a series of 
tests. For blank 1000l Cholesterol reagents, 
for standard 1000l Total Cholesterol 
reagents and 10l Cholesterol standard and 
for test sample 1000l Cholesterol reagents 
with 10l Supernatant were mixed well and 
then incubated at incubate at 37C for 5 
minutes or room temperature for 10-15 
minutes. Finally, read the result with 
Analyzer/ Colorimeter/ Spectrophotometer 
against Reagent Blank. 
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Test procedure for GPT 
For sample preparation 1000 µl of 
Working Reagents and 100 µl of Sample 
were mixed and recorded immediately after 
1 minute and at the same time the stop 
watch started. Record the absorbance again 
exactly after 1, 2 and 3 minute. Finally, read 
the result with 
analyzer/Colorimeter/Spectrophotometer 
against Reagent Blank. 
Test procedure for GOT 
For sample preparation 1000 µl of 
Working Reagents and 100 µl of Sample 
were mixed and recorded immediately after 
1 minute and at the same time the stop 
watch started. Record the absorbance again 
exactly after 1, 2 and 3 minute. Finally, read 
the result with analyzer/ Colorimeter/ 
Spectrophotometer against Reagent Blank. 
Test procedure for ALP 
For sample preparation 1000 µl of 
Working Reagents and 20 µl of sample were 
mixed and recorded immediately after 1 
minute and at the same time the stop watch 
started. Record the absorbance again exactly 
after 1, 2 and 3 minute. Finally, read the 
result with 
analyzer/Colorimeter/Spectrophotometer 
against Reagent Blank. 
RESULT AND DISCUSSION 
Balajirakadi Kvatha Curna (BLJ), a 
classical Ayurvedic preparation which is 
used in cough, was studied for its 
toxicological aspects after chronic 
administrations for 45 consecutive days. 
Serum protein/ Albumin (Male and 
Female) 
In the male rats there was increase in 
both the Total protein and the Albumin 
content in the plasma. None of these changes 
were significantly different from their 
corresponding control values. In the female 
rats there was increase in both the Total 
protein and the Albumin content in the 
plasma. None of these changes were 
significantly different from their 
corresponding control values. On the other 
hand, In the female rats there was increase 
in both the Total protein and the Albumin 
content in the plasma. None of these changes 
were significantly different from their 
corresponding control values. The result was 
showed in Table no.2 and Figure no. 1& 2. 
Table 2: Serum protein/ Albumin (Male and Female) 
Control Male Balajirakadi Kvatha Curna (BLJ) Male 
Total protein 4237.245 ± 67.3245 4288.2074 ± 61.3636(% incr.) (p=0.883) 
Albumin 3451.7416 ± 85.3068 3495.0376 ± 65.4994(% incr.) (p=0.916) 
Control Female Balajirakadi Kvatha Curna (BLJ) Female 
Total protein 4608.3282 ± 113.2184 4666.0452 ± 100.9946(% incr.) (p=0.915) 
Albumin 3605.9857 ± 65.7737 3674.5754 ± 68.4848(% incr.) (p=0.812)*** 
Lipid profile (Male and Female) 
Cholesterol and triglyceride tests are 
blood tests that measure the total amount of 
fatty substances (cholesterol and 
triglycerides) in the blood. 
Cholesterol travels through the blood 
attached to a protein. This cholesterol-
protein package is called a lipoprotein. 
Lipoprotein analysis (lipoprotein profile or 
lipid profile) measures blood levels of total 
cholesterol, LDL cholesterol, HDL 
cholesterol, and triglycerides. A high LDL 
cholesterol level may increase your chances 
of developing heart disease. A high VLDL 
cholesterol level can cause the buildup of 
cholesterol in your arteries and increases 
your risk of heart disease and stroke. Having 
a high triglyceride level along with a high 
LDL cholesterol may increase your chances 
of having heart disease more than having 
only a high LDL cholesterol level[17-18]. 
In the human body, high levels of 
triglycerides in the bloodstream have been 
linked to atherosclerosis, and, by extension, 
the risk of heart disease and stroke. 
However, the relative negative impact of 
raised levels of triglycerides compared to 
Sujit Biswas Et Al. In-vivo Characterization of Total Protein, Albumin Content, Lipid Profile and 
Enzymatic Property of Balajirakadi Kvatha Curna (Blj) In Albino Rats’ Plasma 
 Available online at : http://ijapr.in Page 32 
that of LDL:HDL ratios is as yet unknown. 
The risk can be partly accounted for by a 
strong inverse relationship between 
triglyceride level and HDL-cholesterol level. 
Another disease caused by high triglycerides 
is pancreatitis. 
In this investigation an increase of 
plasma triglyceride level in the BLJ treated 
male rats was observed which was not 
statistically significant but was noticeable 
(p=0.066) in comparison to control. On the 
contrary there was decrease in the total 
Cholesterol, VLDL, LDL and HDL. Highly 
significant (p=0.004) decrease was observed 
with Total Cholesterol and a significant 
(p=0.027) decrease was observed with 
VLDL. Non significant decrease was 
observed with LDL and HDL In case of HDL 
though the decrease was not statistically 
significant but it was noticeable (p=0.066). 
In the female rats there was an increase in 
the Triglycerides content in the plasma 
which was not statistically significant. On the 
contrary there was decrease in the total 
Cholesterol, VLDL and HDL. The decrease in 
total Cholesterol was statistically significant, 
in case of VLDL content, the decrease was 
statistically highly significant. Surprisingly 
the LDL content was almost similar to the 
corresponding control value. It would be 
interestingly to note that the decrease in 
HDL was not significant. The result was 
showed in Table no.3 and Figure no. 3& 4. 
Table 3: Lipid profile (Male and Female) 
Control Male Balajirakadi Kvatha Curna (BLJ) Male 
Triglycerides 85.4456 ± 1.4729 94.9688 ± 1.5324 (% incr.) (p=0.066) 
Total cholesterol 61.8788 ± 1.4292 54.4066 ± 1.4775 (% decr.) (p=0.004)** 
VLDL 13.7576 ± 0.5752 12.0829 ± 0.3502 (% decr.) (p=0.027)* 
LDL 16.4315 ± 0.6355 16.0175 ± 0.5875 (% decr.) (p=0.792) 
HDL 28.2076 ± 0.7572 25.0204 ± 0.9668 (% decr.) (p=0.068) 
Control Female Balajirakadi Kvatha Curna (BLJ) Female 
Triglycerides 77.4925 ± 2.5716 82.9924 ± 2.4914 (% incr.) (p=0.239) 
Total cholesterol 59.1491 ± 1.2942 54.4805 ± 1.5616 (% decr.) (p=0.042)* 
VLDL 13.8558 ± 0.4353 11.9178 ± 0.4923 (% decr.) (p=0.002)** 
LDL 14.9734 ± 0.5224 15.0676 ± 0.5356 (% incr.) (p=0.819) 
HDL 25.8685 ± 0.7505 23.4975 ± 0.7983 (% decr.) (p=0.181) 
Enzymatic activity 
In medicine, the presence of elevated 
transaminases, commonly the transaminases 
alanine transaminase (ALT) and aspartate 
transaminase (AST), may be an indicator of 
liver damage.[19] These levels previously 
were called the serum glutamate-pyruvate 
transaminase (SGPT) and the serum 
glutamate-oxaloacetate transaminase 
(SGOT). Elevated levels are quite sensitive 
for liver injury, meaning that they are likely 
to be present if there is injury. However, 
they may also be elevated in other 
conditions. ALT is not commonly found 
outside the liver; AST too is most commonly 
found in the liver, but also in significant 
amounts in cardiac (heart) and skeletal 
muscle. In fact, measurement of these used 
to be part of diagnosing heart attacks, 
although newer enzymes and proteins that 
are more specific for cardiac damage have 
largely replaced this usage. In general, any 
damage to the liver will cause medium 
elevations in these transaminases (usually 
called liver enzymes, though of course they 
are not the only enzymes in the liver)[20-21]. 
A statistically very highly significant 
increase in the sGPT, sGOT and ALP 
activities in the plasma was found in male 
rats. The female rats showed a statistically 
very highly significant decrease in the sGPT 
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and sGOT activities. In case of ALP activities 
in the plasma, a statistically insignificant 
decrease was noted in this rat group. The 
result was showed in Table no.4 and Figure 
no. 5& 6. 
Table 4: Plasma enzymatic activity through sGPT, sGOT, ALP 
Control Male 
Balajirakadi Kvatha Curna (BLJ) 
Male 
sGPT 51.3336 ± 0.1096 
65.6072 ± 0.3098 (% incr.) 
(p=0.001)*** 
sGOT 88.4264 ± 0.2426 
101.6286 ± 1.1788 (% incr.) 
(p=0.001)*** 
ALP 36.2738 ± 0.0883 
46.6092 ± 0.4054 (% incr.) 
(p=0.001)*** 
Control Female 
Balajirakadi Kvatha Curna (BLJ) 
Female 
sGPT 41.3264 ± 0.1078 
39.9004 ± 0.06215 (% decr.) 
(p=0.001)*** 
sGOT 70.2885 ± 0.1625 
68.3105 ± 0.1505 (% decr.) 
(p=0.001)*** 
ALP 28.7365 ± 0.07946 28.6516 ± 0.09427(% decr.) (p=0.629) 
CONCLUSION 
Balajirakadi Kvatha Curna (BLJ), a 
classical Ayurvedic preparation which is 
used in cough by the rural and poor people 
in Bangladesh. By the characterization of 
toxicological study of Balajirakadi Kvatha 
Curna we get some significant result in both 
male and female rats in case of lipid profile 
(total cholesterol, VLDL and HDL) among the 
study of total protein, albumin content, lipid 
profile and enzymatic activity. In addition to 
this study it was observed that it causes few 
impacts on some parameters like total 
protein and albumin content. Although lipid 
profile with enzymatic activity in rats’ 
plasma after chronic administration showed 
significant impacts. A statistically very highly 
significant increase in the sGPT sGOT and 
ALP activities in the plasma was found in 
male rats while in the female rats it has been 
showed a statistically very highly significant 
decrease in the sGPT and sGOT activities. 
But in case of ALP activities in the plasma, a 
statistically insignificant decrease was noted 
in this rat group. Although some recorded 
result is not statistically significant and 
noncongruent in case of both male and 
female rats (HDL content) which may trigger 
subtle further experiment to find out more 
valid and congruent result to claim freedom 
from discrepancy.  
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Figure 1: Comparative presentation of Effect of Balajirakadi Kvatha Curna (BLJ) on total serum 
protein and albumin between male control group and drug treated male rats. 
 
Figure 2: Comparative presentation of Effect of Balajirakadi Kvatha Curna (BLJ) on total serum 
protein and albumin between female control group and drug treated female rats. 
  
Figure 3: Comparative presentation of Effect of Balajirakadi Kvatha Curna (BLJ) on lipid profile 
(Triglycerides, Total cholesterol, VLDL=Very low density lipoprotein, LDL=Low density 
lipoprotein and HDL=High density lipoprotein ) between male control group and drug treated 
male rats. 
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Figure 4: Comparative presentation of Effect of Balajirakadi Kvatha Curna (BLJ) on lipid profile 
(Triglycerides, Total cholesterol, VLDL=Very low density lipoprotein, LDL=Low density 
lipoprotein and HDL=High density lipoprotein) between female control group and drug treated 
female rats. 
 
Figure 5: Comparative presentation of Effect of Balajirakadi Kvatha Curna (BLJ) on enzymatic 
property (sGPT, sGOT and ALP) between male control group and drug treated male rats.
 
Figure 6: Comparative presentation of Effect of Balajirakadi Kvatha Curna (BLJ) on enzymatic 
property ( sGPT, sGOT and ALP) between female control group and drug treated female rats. 
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